Antioxidants for male subfertility
- PMID: 21249690
- DOI: 10.1002/14651858.CD007411.pub2
Antioxidants for male subfertility
Update in
-
Antioxidants for male subfertility.Cochrane Database Syst Rev. 2014;(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD007411. doi: 10.1002/14651858.CD007411.pub4. PMID: 25504418 Updated.
Abstract
Background: Between 30% to 80% of male subfertility cases are considered to be due to the damaging effects of oxidative stress on sperm. Oral supplementation with antioxidants may improve sperm quality by reducing oxidative stress.
Objectives: This Cochrane review aimed to evaluate the effect of oral supplementation with antioxidants for male partners of couples undergoing assisted reproduction techniques (ART).
Search strategy: We searched the Cochrane Menstrual Disorders and Subfertility Group Register, CENTRAL (The Cochrane Library), MEDLINE, EMBASE, CINAHL, PsycINFO and AMED databases (from their inception until Febuary 2010), trial registers, sources of unpublished literature, reference lists and we asked experts in the field.
Selection criteria: We included randomised controlled trials comparing any type or dose of antioxidant supplement (single or combined) taken by the male partner of a couple seeking fertility assistance with placebo, no treatment or another antioxidant. The outcomes were live birth, pregnancy, miscarriage, stillbirth, sperm DNA damage, sperm motility, sperm concentration and adverse effects.
Data collection and analysis: Two review authors independently assessed studies for inclusion and trial quality, and extracted data.
Main results: We included 34 trials with 2876 couples in total. Live birth: three trials reported live birth. Men taking oral antioxidants had an associated statistically significant increase in live birth rate (pooled odds ratio (OR) 4.85, 95% CI 1.92 to 12.24; P = 0.0008, I(2) = 0%) when compared with the men taking the control. This result was based on 20 live births from a total of 214 couples in only three studies.Pregnancy rate: there were 96 pregnancies in 15 trials including 964 couples. Antioxidant use was associated with a statistically significant increased pregnancy rate compared to control (pooled OR 4.18, 95% CI 2.65 to 6.59; P < 0.00001, I(2) = 0%).Side effects: no studies reported evidence of harmful side effects of the antioxidant therapy used.
Authors' conclusions: The evidence suggests that antioxidant supplementation in subfertile males may improve the outcomes of live birth and pregnancy rate for subfertile couples undergoing ART cycles. Further head to head comparisons are necessary to identify the superiority of one antioxidant over another.
Comment in
-
Words of wisdom. Re: antioxidants for male subfertility.Eur Urol. 2012 Sep;62(3):566-7. doi: 10.1016/j.eururo.2012.06.022. Eur Urol. 2012. PMID: 22850203 No abstract available.
Similar articles
-
Antioxidants for male subfertility.Cochrane Database Syst Rev. 2014;(12):CD007411. doi: 10.1002/14651858.CD007411.pub3. Epub 2014 Dec 15. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD007411. doi: 10.1002/14651858.CD007411.pub4. PMID: 25504418 Updated.
-
Antioxidants for male subfertility.Cochrane Database Syst Rev. 2022 May 4;5(5):CD007411. doi: 10.1002/14651858.CD007411.pub5. Cochrane Database Syst Rev. 2022. PMID: 35506389 Free PMC article.
-
Antioxidants for female subfertility.Cochrane Database Syst Rev. 2017 Jul 28;7(7):CD007807. doi: 10.1002/14651858.CD007807.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Aug 27;8:CD007807. doi: 10.1002/14651858.CD007807.pub4. PMID: 28752910 Free PMC article. Updated.
-
Assisted reproductive technologies for male subfertility.Cochrane Database Syst Rev. 2016 Feb 26;2(2):CD000360. doi: 10.1002/14651858.CD000360.pub5. Cochrane Database Syst Rev. 2016. PMID: 26915339 Free PMC article.
-
Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. doi: 10.1002/14651858.CD003053.pub6. Cochrane Database Syst Rev. 2017. PMID: 29183107 Free PMC article.
Cited by
-
Combination therapy with antioxidants improves total motile sperm counts: A Preliminary Study.Reprod Med Biol. 2019 Nov 28;19(1):89-94. doi: 10.1002/rmb2.12308. eCollection 2020 Jan. Reprod Med Biol. 2019. PMID: 31956290 Free PMC article.
-
A translational medicine appraisal of specialized andrology testing in unexplained male infertility.Int Urol Nephrol. 2014 Jun;46(6):1037-52. doi: 10.1007/s11255-014-0715-0. Epub 2014 Apr 27. Int Urol Nephrol. 2014. PMID: 24771472 Review.
-
Lifestyle factors and reproductive health: taking control of your fertility.Reprod Biol Endocrinol. 2013 Jul 16;11:66. doi: 10.1186/1477-7827-11-66. Reprod Biol Endocrinol. 2013. PMID: 23870423 Free PMC article. Review.
-
Modifiable Risk Factors and Infertility: What are the Connections?Am J Lifestyle Med. 2014;10(4):220-231. doi: 10.1177/1559827614558020. Epub 2014 Dec 16. Am J Lifestyle Med. 2014. PMID: 27594813 Free PMC article.
-
Dietary Supplements for Male Infertility: A Critical Evaluation of Their Composition.Nutrients. 2020 May 19;12(5):1472. doi: 10.3390/nu12051472. Nutrients. 2020. PMID: 32438678 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical